SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77654.60
888.68 (1.16%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Jubilant Pharmova Ltd.	Q V+ PT	15,366 Small Cap	977.90 (1.37%)	772.15	6.65	-24.99	-38.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Suven Life Sciences Ltd.	Q V+ PT	8,314 Small Cap	313.25 (6.46%)	N/A	4.74	-14.30	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Aster DM Quality Care Ltd.	Q V+ PT	70,919 Mid Cap	817.95 (0.53%)	182.72	14.39	-13.71	0.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Panacea Biotec Ltd.	Q V+ PT	2,540 Small Cap	424.20 (2.28%)	N/A	8.91	-8.75	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Sanofi India Ltd.	Q V PT	7,743 Small Cap	3,422.45 (1.79%)	24.99	9.93	-8.74	-7.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Nectar Lifesciences Ltd.	Q V PT	199 Small Cap	10.20 (-0.29%)	N/A	0.34	-6.71	-232.05	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Novartis India Ltd.	Q V+ PT	3,898 Small Cap	1,595.75 (1.07%)	39.87	4.59	-4.06	54.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Aurobindo Pharma Ltd.	Q V+ PT	89,212 Mid Cap	1,590.80 (2.60%)	36.94	3.93	-3.95	-0.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,28,055 Large Cap	8,931.65 (0.29%)	85.79	12.85	-3.49	29.94	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Solara Active Pharma Sciences Ltd.	Q V PT	2,446 Small Cap	506.25 (-0.15%)	N/A	1.92	-0.58	-134.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Onesource Specialty Pharma Ltd.	Q V PT	19,809 Small Cap	1,748.10 (1.20%)	415.98	3.3	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Aarti Pharmalabs Ltd.	Q V+ PT	6,129 Small Cap	682.85 (1.04%)	34.78	3.09	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	IOL Chemicals And Pharmaceuticals Ltd.	Q V+ PT	4,315 Small Cap	147.55 (0.37%)	31.35	2.4	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Nephrocare Health Services Ltd.	Q V+ PT	6,927 Small Cap	703.90 (2.18%)	N/A	7.27	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Gujarat Kidney And Super Speciality Ltd.	Q V PT	1,001 Small Cap	127.10 (0.08%)	101.13	4.06	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Blue Jet Healthcare Ltd.	Q V PT	10,836 Small Cap	602 (5.15%)	43.73	5.02	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Fabtech Technologies Ltd.	Q V PT	664 Small Cap	149.65 (0.20%)	19.26	1.7	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	10,860 Small Cap	4,704.40 (-0.23%)	42.11	24.04	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Laxmi Dental Ltd.	Q V PT	1,181 Small Cap	217.70 (1.35%)	71.87	4.78	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Park Medi World Ltd.	Q V+ PT	11,997 Small Cap	279.25 (0.54%)	327.64	13.95	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Krsnaa Diagnostics Ltd.	Q V+ PT	1,731 Small Cap	533.90 (0.07%)	17.06	1.77	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Senores Pharmaceuticals Ltd.	Q V+ PT	6,108 Small Cap	1,320.10 (-0.47%)	328.57	8.13	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Granules India Ltd.	Q V+ PT	20,957 Small Cap	841.65 (-0.48%)	52.01	5.11	2.07	-5.88	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Pfizer Ltd.	Q V PT	21,527 Small Cap	4,754.75 (1.04%)	29.28	5.12	2.39	8.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Biocon Ltd.	Q V PT	70,452 Mid Cap	430.85 (-0.34%)	1893.86	2.58	2.96	-18.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Strides Pharma Science Ltd.	Q V+ PT	9,604 Small Cap	1,060 (1.73%)	52.3	2.93	3.25	-0.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Fermenta Biotech Ltd.	Q V PT	1,343 Small Cap	451.45 (-1.05%)	20.89	3.2	3.85	-0.38	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Hikal Ltd.	Q V+ PT	2,676 Small Cap	221.10 (1.87%)	N/A	2.23	4.29	-1.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Procter & Gamble Health Ltd.	Q V+ PT	11,088 Small Cap	6,616.80 (-0.95%)	33.92	21.14	4.31	11.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Wockhardt Ltd.	Q V+ PT	30,660 Small Cap	1,916.45 (1.57%)	143.94	6.22	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Artemis MedicareServ	299.10	7.90%
Suven Life Sciences	313.25	6.46%
Concord Biotech	1,330.10	6.05%
Blue Jet Healthcare	602	5.15%
Divis Laboratories	7,794	5.03%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Kopran	190.40	-4.35%
Fischer Medical	35.84	-2.71%
Wanbury	306.20	-2.02%
3B Blackbio Dx	1,271.90	-1.87%
Shree Ganesh Remed.	611.90	-1.54%

News about Top Pharma Companies in India

Jul, 2026

Solara Active Pharma Sciences informs about conference call

Solara Active Pharma Sciences has informed that it enclosed the transcript of earnings conference call for the quarter ended June 30, 2026, conducted on Thursday, July 23, 2026, after the meeting of Board of Directors. The above information is also available on the website of Company at: https://solara.co.in/investorrelations/investor-update.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Biocon’s arm secures Health Canada’s nod for Yesintek (ustekinumab) Autoinjector Pen

This approval further strengthens the company’s portfolio of immunology products in Canada

Jul, 2026

Biocon informs about company statement

Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Receives Health Canada Approval for Yesintek® (ustekinumab) Autoinjector Pen’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Pfizer - Quaterly Results

The company witnessed a 8.31% growth in the revenue at Rs. 6531.70 millions for the quarter ended June 2026 as compared to Rs. 6030.50 millions during the year-ago period.Net profit stood at Rs. 2044.70 millions compared to Rs. 1917.50 millions in the corresponding previous quarter,high by 6.63%.Operating Profit saw a handsome growth to 2924.00 millions from 2771.90 millions in the quarter ended June 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	6531.70	6030.50	8.31	6531.70	6030.50	8.31	25196.50	22813.50	10.45
Other Income	448.40	671.70	-33.24	448.40	671.70	-33.24	1879.50	1722.50	9.11
PBIDT	2924.00	2771.90	5.49	2924.00	2771.90	5.49	10920.40	9124.80	19.68
Interest	14.60	32.50	-55.08	14.60	32.50	-55.08	94.80	84.10	12.72
PBDT	2909.40	2739.40	6.21	2909.40	2739.40	6.21	10334.00	10768.80	-4.04
Depreciation	142.60	144.10	-1.04	142.60	144.10	-1.04	577.30	607.90	-5.03
PBT	2766.80	2595.30	6.61	2766.80	2595.30	6.61	9756.70	10160.90	-3.98
TAX	722.10	677.80	6.54	722.10	677.80	6.54	2532.40	2484.90	1.91
Deferred Tax	12.80	3.90	228.21	12.80	3.90	228.21	-42.80	-156.10	-72.58
PAT	2044.70	1917.50	6.63	2044.70	1917.50	6.63	7224.30	7676.00	-5.88
Equity	457.50	457.50	0.00	457.50	457.50	0.00	457.50	457.50	0.00
PBIDTM(%)	44.77	45.96	-2.61	44.77	45.96	-2.61	43.34	40.00	8.36

Jul, 2026

Senores Pharmaceutic - Quaterly Results

The turnover zoomed to Rs. 269.90 millions, up 67.33% for the June 2026 quarter as against Rs. 161.30 millions during the year-ago period.Net Profit of the company move down -61.85% to Rs. 10.30 millions from Rs. 27.00 millions in the same quarter last year.The company reported a degrowth in operating Profit to 72.20 millions from 72.30 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202606	202506	% Var	202606	202506	% Var	202603	202503	% Var
Sales	269.90	161.30	67.33	269.90	161.30	67.33	1060.90	385.40	175.27
Other Income	95.50	120.80	-20.94	95.50	120.80	-20.94	663.50	219.90	201.73
PBIDT	72.20	72.30	-0.14	72.20	72.30	-0.14	476.70	147.10	224.07
Interest	22.20	17.60	26.14	22.20	17.60	26.14	69.80	65.20	7.06
PBDT	50.00	54.70	-8.59	50.00	54.70	-8.59	406.90	81.90	396.83
Depreciation	36.10	18.80	92.02	36.10	18.80	92.02	132.30	30.80	329.55
PBT	13.90	35.90	-61.28	13.90	35.90	-61.28	274.60	51.10	437.38
TAX	3.60	8.90	-59.55	3.60	8.90	-59.55	72.10	14.20	407.75
Deferred Tax	0.50	5.00	-90.00	0.50	5.00	-90.00	-12.40	-0.30	4033.33
PAT	10.30	27.00	-61.85	10.30	27.00	-61.85	202.50	36.90	448.78
Equity	460.54	460.54	0.00	460.54	460.54	0.00	460.50	460.50	0.00
PBIDTM(%)	26.75	44.82	-40.32	26.75	44.82	-40.32	44.93	38.17	17.73

Jul, 2026

Aurobindo Pharma moves up on entering into non-exclusive voluntary licensing agreement with MSD

Aurobindo Pharma is among a select group of global generic manufacturers to have signed this agreement

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Jubilant Pharmova Ltd.	15,366 Crore
2	Suven Life Sciences Ltd.	8,314 Crore
3	Aster DM Quality Care Ltd.	70,919 Crore
4	Panacea Biotec Ltd.	2,540 Crore
5	Sanofi India Ltd.	7,743 Crore
6	Nectar Lifesciences Ltd.	199 Crore
7	Novartis India Ltd.	3,898 Crore
8	Aurobindo Pharma Ltd.	89,212 Crore
9	Apollo Hospitals Enterprise Ltd.	1,28,055 Crore
10	Solara Active Pharma Sciences Ltd.	2,446 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,720	59,301	38.21	12.49	26.17	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,877	1,86,354	86.14	22.16	44.79	29.04
Lupin Ltd. (M)	Somewhat Good	2,450	1,09,494	20.53	4.89	11.88	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,397	41,675	39.47	9.21	26.67	25.35
Alkem Laboratories Ltd. (M)	Very Good	5,674	67,559	30.92	4.83	22.42	17.86

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,782	94,987	97.82
Sai Life Sciences Ltd. (S)	Very Good	1,314	27,605	57.56
Aurobindo Pharma Ltd. (M)	Very Good	1,591	89,212	37.52
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,877	1,86,354	35.15
Lupin Ltd. (M)	Somewhat Good	2,450	1,09,494	22.15
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Very Good	1,314	27,605	80.84	11.01	42.51	17.75
Ajanta Pharma Ltd. (M)	Very Good	3,397	41,675	39.47	9.21	26.67	13.54
Mankind Pharma Ltd. (M)	Very Good	2,593	1,08,129	53.07	6.61	33.20	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,122	1,09,686	21.76	4.22	13.36	13.52
Lupin Ltd. (M)	Somewhat Good	2,450	1,09,494	20.53	4.89	11.88	13.02

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Lupin Ltd. (M)	Somewhat Good	2,450	1,09,494	20.53	4.89	11.88	32.37
Abbott India Ltd. (M)	Very Good	27,720	59,301	38.21	12.49	26.17	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,143	94,790	29.42	2.48	15.11	15.75
Zydus Lifesciences Ltd. (M)	Very Good	1,122	1,09,686	21.76	4.22	13.36	14.72
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,990	4,74,397	41.33	5.68	23.70	14.41

You have 9 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Solara Active Pharma Sciences informs about conference call

Biocon’s arm secures Health Canada’s nod for Yesintek (ustekinumab) Autoinjector Pen

Biocon informs about company statement

Pfizer - Quaterly Results

Senores Pharmaceutic - Quaterly Results

Aurobindo Pharma moves up on entering into non-exclusive voluntary licensing agreement with MSD

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.